MedTrace Logo

Plasma Free Fatty Acids Profile As A Diagnostic Tool For Acute Ischemic Stroke

NCT03618290 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2020-01-28

No results posted yet for this study

Summary

The purpose of the research is to use plasma free fatty acid profiling as a biomarker for ischemic stroke. The plasma free acid profile will be specifically and significantly changed in early stages upon stroke onset, and correlate with the stroke volume and progression determined by imaging techniques.

Conditions

  • Stroke, Acute

Interventions

DIAGNOSTIC_TEST

Analyze plasma free fatty acid in blood

This study is prospectively designed with the purpose of investigating potential new lipid targets and the free fatty acids as specific markers of acute brain injury. Dynamic measurement of lipid profile in 3 consecutive samples at (I) the time intervals of admission, (II) 8 hours and (III) 24 hours after admission will give the opportunity of comparison mass-spectrometric analysis of highly complex plasma samples thus reducing variability between analyzed samples and allowing precise focusing on essential lipid target changes during stroke progression.

Sponsors & Collaborators

  • University of North Dakota

    collaborator OTHER

  • Sanford Health

    lead OTHER

Principal Investigators

  • Vitaliy Starosta, MD · Sanford Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-19
Primary Completion
2020-01-07
Completion
2020-01-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03618290 on ClinicalTrials.gov